An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19 is a research paper published in Frontiers in Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: TR002366
NCATS NIH HHS
Grant: UL1 TR002366
NHLBI NIH HHS
Grant: R01 HL133240
National Institutes of Health
Grant: 5UL1TR002366-04
Frontiers: University of Kansas Clinical and Translational Science Institute
FWCI
2.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals